Share on PinterestAn AI tool may be able to predict GVHD risk, prompting earlier treatment to prevent complications. Image credit: Victor Bordera/Stocksy An AI-based tool may be able to predict …
posttransplant
-
-
Bone marrow transplantion
Healthcare Asia MagazineKing Faisal immunotherapy combats bone marrow transplant relapseKing Faisal in Jeddah has manufactured and introduced a post-transplant booster dose for bone marrow transplant patients..1 day ago
Healthcare Asia MagazineKing Faisal immunotherapy combats bone marrow transplant relapseKing Faisal in Jeddah has manufactured and introduced a post-transplant booster dose for bone marrow transplant patients..1 day ago
-
In an interview with Targeted Oncology, Heather Stefanski, MD, PhD, vice president of the Center for International Blood and Marrow Transplant Research and Clinical Services at NMDP, identifies a critical …
-
I recently attended a webinar hosted by the Gift of Life Donor Program focused on post-traumatic growth. It provided terminology for experiences I’ve been navigating but couldn’t quite articulate. The …
-
Bone marrow transplantion
Outcomes of primary graft failure in acute myeloid leukemia patients following unrelated transplantation with post-transplant cyclophosphamide: a study from the ALWP/EBMT
Bolaños-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, et al. Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis. N Engl J Med. 2023;388:2338–48. Article PubMed PubMed Central Google …
-
The Centers for Medicare and Medicaid Services (CMS) Proposed Policy The department announced it would provide further clarification on Medicare coverage for the types of blood tests that organ transplant …
-
Bone marrow transplantion
Impact of graft CD34+ cell count on hematologic recovery in patients receiving post-transplant cyclophosphamide prophylaxis
by Wenhui Gaoby Wenhui GaoGooptu M, Romee R, St Martin A, Arora M, Al Malki M, Antin JH, et al. HLA haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide-based prophylaxis. Blood. 2021;138:273–82. https://doi.org/10.1182/blood.2021011281. …
-
Bone marrow transplantion
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplants?
Patient characteristics Baseline characteristics of the study population are shown in Table 1. A total of 8,764 patients were included, of whom 7,725 (88%) received his rATG and 1,039 (12%) …
-
A multidisciplinary approach to determining lung transplant candidacy Multidisciplinary selection committee After completing all testing and evaluation requirements, your case will be submitted to the Pulmonary Selection Committee. The committee …
-
My wife, Susan, and I have traveled the world by train, plane, boat, and automobile, finding new adventures. We are currently in Amsterdam. This is my first overseas trip since …